COMPANY INSIGHT

Sponsored by ICCI

ICCI - International Cannabis and Cannabinoids Institute

ICCI, the first Centre of Excellence in the medical cannabis field, is an organisation that combines various institutions and explores the dynamic cannabinoid treatments available. Consequently, ICCI provides services to a broad array of entities around the world that are interested in the development of cannabis and cannabinoid treatments for medicinal purposes.

SHL Group details its approach to the challenges of emerging formulations

ICCI started as a project uniting outstanding experts from the scientific community, patient organizations and the investment company Dioscorides Global Holdings. As a recognized center of excellence, it cooperates with Charles University, the Czech University of Life Sciences in Prague, Masaryk University in Brno, Mendel University in Brno, Hebrew University in Jerusalem and many other institutions and companies around the world.

ICCI’ primary mission is to research the various uses of medical cannabis and has all the right preconditions for doing so. The team of specialists is comprised of both physicians and experts in healthcare systems, as well as leading experts with direct experience with scientific teams of the United Nations Organization, government bodies and organizations. All of this is supported by strong liaisons with patient organizations.

The institute thus removes all possible barriers preventing the development of research on the possibilities of medical cannabis and its utilization. Cooperation with the International Cannabis and Cannabinoids Institute enables everyone with an interest in researching medical cannabis to gain the background and facilities of a top international team, patient experiences and the organizational background of a strong scientific institution.

ICCI has embarked on a mission to advance the world of medical cannabis by providing a wide range of professional services to companies and organisations and ensuring a high quality cannabis education for medical professionals, patients, caregivers, and business professionals.

ICCI SERVICES

  • Research & Development
  • PFC - Patient Focused Certification
  • Accredited Analytical Services
  • CRO - Contract Research Organization
  • Metabolomics Services
  • Medical Professional and Patient Education
  • Plant Research
  • Big Data Services
  • Consulting Services
  • Government Relations
  • Regulatory Affairs
  • Product Development
  • Product Registration

For more information about

ICCI Group:

www.icci.science

info@icci.science

Go to top

Share this article

Go to article: Home | A new era of buyers clubsGo to article: TSS ABGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Capsugel Company InsightGo to article: The pharma industry briefingGo to article: ICCI Company InsightGo to article: ICCIGo to article: Corbion PuracGo to article: Real world data: improving clinical trial outcomesGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Understanding allergic reactions: chronicling the work of Dr Teruko IshizakaGo to article: Scandinavian HealthGo to article: Moehs Iberica SLGo to article: Swiss WorldCargoGo to article: Buyers’ clubs: the first step toward universal UK access to Orkambi?Go to article: TSS Company InsightGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO GmbHGo to article: Prescription dread: measuring psychiatric drugs against the alternativesGo to article: BEAGo to article: ZenatekGo to article: PfanstiehlGo to article: Herd health: agriculture’s role in the global AMR crisisGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Hapa Company InsightGo to article: ConcePTION: tackling the unknowns of medication in pregnancyGo to article: AEB Company Insight Go to article: AEBGo to article: Pfeiffer VacuumGo to article: From start-ups to the SIX Swiss Exchange – a Swiss success storyGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Cancer drug discovery: unravelling the mysteries of halichondrinGo to article: Centaur Clinical | Company InsightGo to article: IDMP is back: what next?Go to article: Charles Ischi Go to article: Adhesives ResearchGo to article: Emirates SkyCargoGo to article: Global labelling management: why does it continue to cause problems?Go to article: B&W TekGo to article: EventsGo to article: Dali Medical devicesGo to article: Spirax Sarco Company InsightGo to article: Spirax SarcoGo to article: Centaur ClinicalGo to article: Next issueGo to article: AralabGo to article: Baxter